NCT07549932Completed
Adjunctive Role of Statin Therapy on Airway Inflammation and Clinical Consequences of Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
This study aimed to evaluate the impact of statin therapy on the clinical consequences, as well as airway inflammation and radiological features, in severe chronic obstructive pulmonary cases.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 19 Apr 2026
- Start date
- 1 Jan 2024
- Primary completion date
- 1 May 2025
- Lead sponsor
- Mohamed Salah El-Sayed
- Diseases
- COPD
- NCT number
- NCT07549932
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 1 Jan 2024 to the primary completion date, 1 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic lung diseases other than COPD as bronchial asthma, interstitial lung disease
- Established indication for statin therapy (atherosclerotic cardiovascular disease, familial hyperlipidemia).
- Chronic debilitating diseases as diabetes mellitus, chronic liver disease, chronic kidney disease, and hematological disorders.
- Known hypersensitivity to statins.
Other
- Acute or chronic Inhalational lung injury.
- Pregnancy/lactation.
- Unable or refuse to provide informed consent.
Who the study is looking for
- Diagnosed Chronic Obstructive Pulmonary Disease per the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria 2025 (post-bronchodilator forced expiratory volume₁/forced vital capacity \< 0.70), meets the definition of grade E Chronic Obstructive Pulmonary Disease by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria 2025 criteria.
- Age ≥ 40 years
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| utpatient clinic and Inpatient quarters of the Thoracic Medicine Department of Mansoura University Hospitals Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.